Authors:
Topol, CE
Califf, RM
Simes, RJ
Van de Werf, F
Diaz, R
Paolasso, E
Aylward, PE
Keech, A
Klein, W
Piegas, L
Tomov, I
Armstrong, PW
Widimsky, P
Grande, P
Halinen, M
Vahanian, A
Neuhaus, K
Dimas, AP
Preda, I
Kristinsson, A
Tzivoni, D
Ardissino, D
White, HD
Madsen, S
Sugrue, D
Sadowski, Z
Seabra-Gomes, R
Apetrei, E
Dalby, A
Betriu, A
Pfisterer, M
Verheugt, F
Fox, K
Bates, ER
Gibler, WB
Granger, CB
Harrington, RA
Hochman, JS
Holmes, DR
Kleiman, NS
Lee, KL
Moliterno, DJ
Newby, LK
Ohman, EM
Califf, R
Newby, K
Zillman, L
Lee, K
Lemons, P
McCourt, B
Campbell, C
Tardiff, B
Snapp, J
Bassett, K
Hodgson, P
Hannan, K
Kandzari, L
Hawkins, S
Hinman-Smith, E
McDougal, M
Raffetto, K
Thompson, D
Wehrle, T
Ange, C
Brown, R
Grissom, G
Heuckel, M
McCall, J
Pennachi, W
Spychala, M
Veasey, S
Pullium, M
Journey, T
Quintero, K
Mark, D
Davidson-Ray, L
Diner, L
Nelson, C
Sowers, C
Webb, G
Young, M
Bhapkar, M
Pacchiana, C
Sparapani, R
Tuttle, R
Weaver, D
Borzak, S
Douthat, L
Topol, E
Moliterno, D
Konczos, L
Baishnab, R
Baishnab, R
Bakos, A
Blashford, L
Bratsch, J
Brown, K
Cadorini, E
Carlson, J
Clemmons, P
DelValle, M
Drabik, M
Fu, G
Gates, K
Gibson, Y
Heil, L
Hill, N
Klancar, R
McHale, B
Montague, E
Pasca, N
Pergi, L
Randall, R
Rosso, R
Sankovich, K
Smith, D
Wisniewski, L
Witkowski, M
Zovkic, V
Alexander, K
Bhatt, D
Brener, S
Campbell, L
Cho, L
Cole, C
Deedy, M
Foody, J
Gassler, J
Ghaffari, S
Haas, G
Kapadia, S
Lauer, M
Lauer, MS
Lincoff, M
Lutton, S
Marso, S
Mukherjee, D
Patel, V
Penn, M
Robbins, M
Roe, M
Sila, C
Thamilarasan, M
Wagner, G
Armstrong, P
Bestilny, S
Van de Werf, F
Budts, W
Graux, S
Luyten, A
Simes, J
Keech, A
Kava, M
Bower, T
Chan, S
Crampton, L
Monro, C
Nayak, M
Parente, G
Riley, V
Wilton, D
Aylward, P
Dolan, S
Thomas, C
White, H
Scott, M
Frye, R
Alpert, J
Bertrand, M
Ryan, T
Fisher, L
Asarch, L
Smith, M
Lim, L
Bokslag, M
Chiu, P
Chung, J
Collins, S
Dougherty, C
Guimaraes, D
Hakim, Z
Mathieson, J
Montgomery, L
Novotny, B
Steiner, B
Wittke, B
Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345
Authors:
Pendergraft, WF
Alcorta, DA
Segelmark, M
Yang, JJ
Tuttle, R
Jennette, JC
Falk, RJ
Preston, GA
Citation: Wf. Pendergraft et al., ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells, KIDNEY INT, 57(5), 2000, pp. 1981-1990
Authors:
Tuttle, R
Nakagawa, Y
Johnson, JE
O'Leary, DDM
Citation: R. Tuttle et al., Defects in thalamocortical axon pathfinding correlate with altered cell domains in Mash-1-deficient mice, DEVELOPMENT, 126(9), 1999, pp. 1903-1916
Citation: Je. Braisted et al., Thalamocortical axons are influenced by chemorepellent and chemoattractantactivities localized to decision points along their path, DEVELOP BIO, 208(2), 1999, pp. 430-440
Authors:
McClure, MW
Berkowitz, SD
Sparapani, R
Tuttle, R
Kleiman, NS
Berdan, LG
Lincoff, AM
Deckers, J
Diaz, R
Karsch, KR
Gretler, D
Kitt, M
Simoons, M
Topol, EJ
Califf, RM
Harrington, RA
Citation: Mw. Mcclure et al., Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome - The platelet glycoprotein IIb IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial experience, CIRCULATION, 99(22), 1999, pp. 2892-2900